Cameco Zen Horizon Research: Western Uranium Champion, but the Price Has Prepaid Too Much for the Nuclear Revival

Hunting ten-year five-baggers among great growth stocks — pressing the upside question: "Can it get much bigger?"

• QHow high is its market ceiling? Is it expanding an existing pie, or creating an entirely new market?5/10

  A

  Net view: the ceiling is real but bounded. Cameco is almost entirely expanding an existing commodity pie, rather than creating a new market. Uranium is an established commodity market with nearly 70 years of history, and demand is already structurally locked in by more than 440 operating reactors. The AI-to-nuclear revival brings a structural repricing and possible doubling in volume for this pie (WNA expects reactor uranium requirements of about 68,920 tU in 2025 to rise to >150,000 tU by 2040 in the Reference scenario, roughly doubling), not a new category. By Baillie Gifford's yardstick of a large ten-year opportunity, ideally a new market, Cameco scores only middling on this question: the opportunity is large and structurally upward over a ten-year horizon, but it is an expansion of an existing cyclical commodity market, with the ceiling constrained by oligopolistic supply, the uranium price cycle, and secondary supply. It lacks the new demand curve with exponential penetration that LTGG prefers.

  1. First separate "expanding the pie" from "opening a new market"

  The core of Baillie Gifford's Q1 is this: are you taking a larger share of an established pool, or creating a demand pool that did not previously exist? For Cameco, the answer is clearly the former:

  • Uranium's end use is highly singular: fuel for nuclear reactors. This is an existing commodity market whose demand side is rigidly determined by installed capacity. It is not a case of using uranium to create a new product category or activating customers who previously did not consume uranium. The main report also characterizes it as a "high-quality cyclical growth business" and a "classic strong-cycle company whose earnings and share price are tightly linked to uranium prices" (Section 4).
  • Cameco's own addressable space equals "annual global reactor uranium procurement x the share it can win x realized price." In FY2025, its uranium segment sold 33.0M lb, produced 21.0M lb, realized US$62.11/lb (=CAD$87.00/lb), and generated CAD$2,874M in uranium revenue, about 83% of total revenue. That is the slice it currently cuts from the existing pie.

  So "how high is the ceiling" has to be split into two questions: how large can this existing pie become, and how large and how expensive a slice can Cameco take?

  2. The ceiling of the pie itself: a real ten-year doubling, the part that most resembles growth equity

  This is the only part of the Cameco story that has the color of a large structural opportunity, and the reason it can borrow Baillie Gifford language:

  • Demand roughly doubles, with ten-year visibility: WNA's 2025 World Nuclear Fuel Report has reactor uranium requirements rising from about 68,920 tU in 2025 to >150,000 tU by 2040 in the Reference scenario, with the Upper scenario at >204,000 tU and the Lower scenario at >107,000 tU; Reference nuclear capacity reaches 746 GWe by 2040. The drivers are real: AI data center power demand is igniting a nuclear revival, including Microsoft's Three Mile Island restart, Google/Amazon nuclear power agreements (Sections 1 and 4), and the COP28 pledge to triple nuclear power by 2050.
  • The supply side has a structural gap, making the pie "thicker": primary mine supply covered only about 90% of annual demand in 2024, leaving an annual gap of roughly 30–40M lbs filled by increasingly depleted secondary supply (inventories), while secondary supply is expected to fall from about 14% in 2025 to about 4% in 2050. A widening gap lifts the bargaining power of operating, low-cost tier-one assets, exactly Cameco's Cigar Lake and McArthur River, and pushes long-term contract prices higher (the long-term uranium price has risen to about US$94/lb, an 18-year high).

  Net reading: the pie itself may double over ten years, and operating assets carry a scarcity premium. That is the substance of Cameco's "growth". But all of this still happens inside the existing market of uranium as reactor fuel. It is the same pie getting larger, not a new pie.

  3. Is growth driven by price or volume? Volume gives direction, price gives elasticity, and price volatility is the dominant risk

  An honest breakdown, because Baillie Gifford would press on the quality of growth:

  • Volume (capacity/gap) provides the ten-year direction and base: the 2040 doubling in demand is a volume story. It means the pie is not shrinking and is structurally upward over the long term. But Cameco's own volume growth is restrained. Management's tone is that "disciplined supply is a strategic cornerstone" and it will not chase volume for volume's sake. 2026 production guidance is only 19.5–21.5M lb; long-term contracts cover about 230M lbs, with an average of about 28M lbs per year over the next five years. In other words, it does not grow revenue by aggressively producing more volume. It collects higher prices in a deficit through scarce assets and contract discipline.
  • Price (the uranium cycle) provides the upside, and the largest uncertainty: most of Cameco's near-term earnings elasticity comes from uranium prices. Historically, uranium spot peaked around $137/lb in 2007 and fell below $18/lb in 2016; spot has already retreated from about $101/lb in 2026-01 to about $86/lb. This means its ceiling at any given point is redefined by the uranium price cycle: a cyclical upswing gives a Davis double play, while a downturn gives a Davis double kill. That is exactly what Baillie Gifford is most wary of. LTGG wants volume growth driven by demand penetration that can be linearly extrapolated for ten years, not price growth from a commodity cycle. In Cameco's growth, price carries too much weight, and price is cyclical. That is the structural flaw separating it from true growth equities.

  4. The three ceilings on the ceiling: oligopolistic supply, price cycles, and secondary/SMR alternatives

  The constraints on the opportunity need to be stated plainly:

  1. Oligopolistic supply can actively cap the upside: uranium supply is highly concentrated. The global leader Kazatomprom (the lowest-cost ISR producer) has announced a roughly 10% cut to its 2026 production plan, from about 32,777 tU (about 85M lb) to about 29,697 tU (about 77M lb), and stated that current supply-demand conditions and uncovered demand are not sufficient to incentivize a return to 100% capacity. This cuts both ways. Its current production restraint supports prices and benefits Cameco, but it also controls the world's lowest-cost and largest body of idle capacity. Once uranium prices are high enough, Kazatomprom, Cameco's own idle tier-one capacity, and other developers such as NXE/UEC can add volume and press the price ceiling lower. The iron law of commodity markets is that high prices cure high prices.
  2. The price cycle itself is the ceiling: third-party fair values (GF Value $64.62, Simply Wall St DCF about $47, Intellectia $52–87) are generally below the current price of $114, while PE-TTM is about 107× and EV/EBITDA about 50–78×, near historical peaks. The market has already prepaid the structural story of demand doubling and deficits widening. Put differently, a meaningful portion of the larger-pie dividend has already been pulled into today's valuation, compressing the "unpriced space" left for shareholders ten years out.
  3. Secondary supply and SMR/technology pathways divert part of the story: inventories, reprocessing, enrichment tails, and other secondary supply still fill part of the gap. At the same time, reactor efficiency gains and improved fuel utilization dilute uranium demand per unit of installed capacity. SMR/advanced reactors deserve separate treatment. They are often framed as "new demand," but their fuel is HALEU (5–20% enrichment), a new category in the enrichment stage dominated by enrichers such as Centrus, Orano, and Urenco, with commercial supply expected only in 2027. Cameco is not the leader in HALEU enrichment. Its position remains at the front end: natural uranium mining plus UF₆ conversion. Even if SMR volumes scale, the meaning for Cameco is only that the same natural uranium pie gets a bit thicker, not that it opens a proprietary new market. The asset closest to a "new market" option is Westinghouse (49% interest, AP1000 reactors plus fuel fabrication), but that is a reactor construction business, not consolidated, and still reporting accounting losses (our share of book net income in FY2025 was only +$58M). It remains far from being a new growth pole for the Cameco core.

  5. Net judgment against the Baillie Gifford standard

  Baillie Gifford expectation for Q1	Cameco reality	Fit
  Large ten-year opportunity	Demand roughly doubles by 2040 and the deficit widens; the space is real and large	Strong
  Ideally creates a new market	It expands an existing commodity pie, with no new category or new customer group	Weak
  Growth can be linearly extrapolated and is mostly volume-driven	Volume gives direction, but price (the uranium cycle) carries too much weight and is highly volatile	Somewhat weak
  The space is not fully priced and remains for long-term shareholders	The deficit narrative has already been prepaid in valuation (PE 107×, far above fair value)	Weak
  The ceiling is not easily capped by supply or substitutes	Constrained by oligopolistic output increases, the price cycle, and secondary supply/SMR diversion	Somewhat weak

  Conclusion: Cameco's market ceiling is not low in absolute value and is structurally upward over a ten-year horizon. That is its real claim to a major secular theme. But it is expanding an existing, cyclical commodity pie, not creating a new market. Growth is driven jointly by volume for direction and price for elasticity, and the cyclicality of price is exactly the growth source least favored by the Baillie Gifford framework. Add oligopolistic supply that can cap prices at any time and a deficit dividend already prepaid by a high valuation, and this ceiling is a bounded repricing of an existing market. By LTGG's yardstick of large ten-year space, ideally a new market, this question scores "middling": it passes on space, but fails on new market, extrapolatable volume growth, and underpricing. That matches the overall framing of the report: Watch, strong cycle, and the price has prepaid too much of the nuclear revival.

  Jun 4, 2026
• QCan its revenue at least double over the next five years? Is growth mainly driven by volume, price, or new businesses?4/10

  A

  Net view: a five-year revenue doubling (CAD$3,482M → ~$7B) is possible, but the probability is low and the quality is poor. It is not the structural, repeatable volume growth Baillie Gifford prefers, but a pulse-like doubling that depends heavily on the strong-cycle uranium price lever hitting a cyclical high. Even if revenue touches $7B in one year, its durability and repeatability should be heavily discounted. One hard anchor: at a time when the "nuclear revival" narrative is hottest and long-term contract prices are at an 18-year high, sell-side consensus still expects only about CAD$5.5B of median revenue in 2030, with a revenue CAGR of only about 7–8%/year over the next three years. This "Buy" consensus path gets only about four-fifths of the way to doubling by 2030 and does not embed a doubling. Doubling is an optimistic branch that requires another step up in uranium prices, not the base case.

  1. Probability: the structural tailwind is real, but FY2025's mere +11% exposes the ceiling from delayed price pass-through

  The bull-side pieces are all present: the long-term uranium price has risen to about US$94/lb, the highest since 2008 (about 18 years), while spot is about US$86/lb; the company has about 230M lbs of long-term contract volume, with average deliveries of about 28M lbs per year over the next five years; on the industry side, WNA expects reactor uranium requirements to rise from about 68,920 tU in 2025 to >150,000 tU by 2040 (roughly doubling), while primary mine supply covers only about 90% of annual demand and the annual gap is about 30–50M lbs. This is a structural tailwind over more than ten years, and the direction is real.

  But FY2025 revenue rose only 11% (CAD$3,136M → $3,482M). That is the key counter-evidence. In a major uranium bull market where prices had already surged from about $30 to $80–100+, the company's revenue rose only 11%. The reason is the moat mechanism identified in the report working against growth speed: long-term contracts with "base-escalated + market-related (with floor/ceiling)" pricing make realized prices lag spot and smooth both rises and falls (FY2025 uranium realized price was US$62.11/lb, clearly below spot at $86), while contracts have both floors that support downside and ceilings that cap upside. This mechanism protects earnings on the way down, but it also limits revenue sensitivity to uranium prices on the way up. A business growing 11% annually would need a sustained CAGR of about 15%/year to double in five years, far above the company's recent growth and sell-side consensus of about 7–8%. Conclusion: possible, but it requires uranium prices to step up again and old low-priced contracts to be gradually replaced by higher-priced new ones. It is not a natural extension.

  2. Source breakdown: most incremental growth comes from uranium price; volume is a slow variable; new businesses are too small to carry a doubling

  Breaking the roughly $3.5B increase from about $3.5B to $7B into three legs shows very different load-bearing capacity:

  • Uranium price (the main load-bearing leg, but the lowest quality): the uranium segment generated CAD$2,874M in FY2025 revenue, about 83% of total revenue, and is the absolute core. Its leverage to total revenue comes almost entirely from realized price, which is determined by the lagging long-term contract book. The arithmetic of a doubling is clear: lifting sales from about 33M lb to about 40M lb, a bit over +20%, is nowhere near enough. It must be combined with a large step up in realized price from CAD$87/lb, requiring spot to stay above $100+ for a long period and pass through into new long-term contracts. This is cyclical price growth, not structural volume growth, and it is the least durable leg.
  • Volume (slow variable, limited elasticity): 2026 production guidance is only 19.5–21.5M lb, broadly flat with FY2025's 21.0M lb, with no steep ramp. Restarting tier-one capacity (full production at McArthur River/Cigar Lake and idle capacity restarts) can add volume, but management's stance is "disciplined supply, not volume for volume's sake." It actively restrains volume to support price, meaning the company chooses not to chase revenue through volume. Add the operational fragility shown by the 2026-05 Saskatchewan floods, which reduced output by about 1.5 million pounds, and the volume leg is steady but slow. It cannot support a doubling on its own.
  • New business/Westinghouse (right direction, small scale, and not consolidated): Westinghouse is accounted for under the equity method, and its revenue is not included in Cameco's consolidated revenue at all. No matter how much Westinghouse grows, it does not directly enter the CAD$3,482M→$7B revenue line. It flows through equity-method net income and distributions. Westinghouse's own official five-year adjusted EBITDA guidance is only 6–10% CAGR; "building 10 AP1000 units before 2030" is a target, not orders. That growth rate also cannot support a parent-level revenue doubling. Fuel services (FY2025 CAD$562M, about 16%) is small and grows modestly. Net conclusion: under consolidated revenue, the second curve contributes almost nothing directly to the doubling. The arithmetic of doubling almost entirely rests on uranium price x sales volume.

  3. Growth quality: a cyclical price pulse, heavily discounted under the Baillie Gifford framework

  This is the most important honest point for this question. Baillie Gifford LTGG prefers sustainable, repeatable volume growth, driven by penetration gains or new-market creation, because that type of growth can still replicate in years 3–10. It is naturally skeptical of a doubling driven by cyclical price pulses, because prices that rise can fall back. Uranium is the textbook example: spot hit $137 in 2007 and fell below $18 in 2016, an 80%+ swing; the report also states that the company had recurring losses or barely profitable years in 2016–2020. So even if revenue reaches $7B at some point within five years, its repeatability is low. It would be a reading from the first half of a Davis double play, symmetrically implying the risk that the second half of a Davis double kill pulls revenue back down (the historical table in the report already shows the cycle-low script of 2021 revenue shrinking to about CAD$1.48B and a $103M loss).

  Therefore two types of "doubling" must be strictly separated:

  • "Doubling at a high point within five years": possible, if uranium prices take another step up, high-priced contracts replace legacy contracts, and full production happens at the same time. This is the optimistic branch, but it is a snapshot of a cyclical top, not a steady state.
  • "Sustainable doubling": insufficient evidence. Sell-side consensus of about 7–8% revenue CAGR and a 2030 center around CAD$5.5B describes moderate growth supported by structural tailwinds, not doubling. Even the most optimistic sell-side models do not make doubling the base case.

  Net judgment for this question: on Q2, Cameco is middling to weak. A revenue doubling is not fantasy, but ① its probability is below the base case (consensus gives only about four-fifths of the path), ② the source is highly concentrated in the cyclical uranium price lever rather than structural volume growth or a consolidatable new business, and ③ the quality is poor, a price pulse rather than repeatable compounding. By Baillie Gifford's standard of favoring sustainable volume growth and discounting cyclical price growth, even if it does double, the durability of that growth should be heavily discounted. It should not be treated as a reliable building block for an LTGG-style fivefold return over the next ten years.

  Jun 4, 2026
• QAfter five years, what becomes the next growth engine? Does this "second curve" exist today?5/10

  A

  Net view: Westinghouse Electric is the only engine that truly deserves to be called Cameco's "second curve," and it is no longer a pure option. It is a growth platform already producing cash. This is likely Cameco's strongest dimension in the Baillie Gifford ten-question framework. But its growth is not smooth, carries strong project pulses and accounting distortions, most AP1000 international orders outside Czech Dukovany remain at framework/early engineering stages, and Cameco's 49% equity-method stake records only net income, not consolidated revenue. Conclusion: Westinghouse is a second curve that has already germinated and begun to deliver, but the market overestimates its linearity while accounting understates it as losses. Its real state is a pulse-like ramping growth platform plus an IPO option triggered only if valuation reaches ≥$30B. Outside Westinghouse, fuel services is a stable cash cow rather than a second curve, while SMR (AP300/eVinci) is a third-curve option beyond ten years and is unlikely to take over within five years.

  1. Why Westinghouse counts as a real second curve rather than a narrative option: it is already producing money. Baillie Gifford wants an engine that can take over after five years and has already germinated today. Westinghouse meets both conditions, and the key point is that it has moved from paper to cash flow: Westinghouse adjusted EBITDA reached US$780M in FY2025 (+61% YoY), while Cameco's 49% share added about $297M of adjusted EBITDA year over year and directly lifted group adjusted EBITDA from CAD$1,531M in 2024 to CAD$1,929M in 2025 (Cameco 2025 results). The harder evidence is cash actually returned: in 2025 Cameco received two cash distributions from Westinghouse totaling about US$220.5M (US$49M in February + US$171.5M in October, the latter directly tied to the Czech Dukovany two-unit construction project, Cameco results). An asset that can wire more than $200 million of cash to the parent and is "outperforming acquisition assumptions" has crossed the threshold from option into growth platform. That is exactly the dimension the report acknowledges as more real than a pure option.

  2. But be honest: its "growth" is pulse-like and distorted by two accounting lenses, not the smooth compounding Baillie Gifford prefers.

  • Accounting distorts downward (book profit remains low): for the same asset, Cameco's 49% share of FY2025 book net income was only +$58M, heavily depressed by about CAD$357M of acquired intangible amortization (report Section 6.2). The divergence between book losses/low profits and rising EBITDA will persist for years. GAAP net income understates it; adjusted EBITDA better captures operating substance.
  • Cash pulses upward (not linearly extrapolatable): the large 2025 distribution relied heavily on milestone collections from the single Dukovany project, and management explicitly does not expect a comparable distribution in 2026. 2026 Westinghouse guidance falls directly to a book net loss of US$(75)–(10)M and adjusted EBITDA of US$370–430M (49% share basis, Cameco 2025 results). EBITDA guidance falls from the $780M high to $370–430M, showing this curve rises and falls with large project milestones rather than compounding upward every year. Baillie Gifford wants the latter from a second curve. Westinghouse is currently the former.

  3. The real quality of the order book: incremental value is real, but most "orders" remain at early engineering stages; only Czech is in construction. This is where the difference between realized and narrative needs the most discipline. After checking sources, the conclusion is that outside Dukovany, new AP1000 "orders" are mostly framework or early engineering arrangements, with varying quality in notice-to-proceed substance:

  • Czech Dukovany (realized): two units are actually under construction. This is the real source of 2025 cash distributions and the EBITDA surge. It is the only part of the order book that has converted into cash.
  • Bulgaria Kozloduy (early engineering): the signed scope is a FEED/engineering services contract plus a 2025-08 first purchase order to a local supplier for NQA-1 quality assurance procedures and structural module mockups, along with MOUs with 30 Bulgarian suppliers (Power Engineering International, Westinghouse purchase order). This is early engineering, far from main construction.
  • Poland Lubiatowo-Kopalino (early/supply chain): orders have been placed with Polish suppliers and the first nuclear power plant is moving forward, but it remains at the supply-chain buildout and early-stage phase (Poland Insight).
  • Ukraine (framework/MOU): memoranda and contracts cover completing Khmelnytskyi Unit 4 and potentially several more units. In substance these are wartime framework agreements, with highly uncertain execution (CEENERGYNEWS).

  Reading: the breadth of the order book is real (Czech/Bulgaria/Poland/Ukraine pipelines), but its depth currently has only Czech converted into revenue and cash. The rest is FEED, supply chain, MOU, and other early/framework work. These are the sources from which the second curve may continue to scale over the next five years, but today they are not realized EBITDA. Treating the entire pipeline as locked-in growth overstates the speed of realization; treating it as air understates the position of the West's only large reactor vendor with an active construction project.

  4. The piece the market values most and sees least clearly: the US$80B U.S. new-build framework plus IPO option. It is an option, but a high-quality option with triggers. On 2025-10-28, Cameco/Brookfield and the U.S. government signed a binding term sheet supporting at least US$80B of AP1000 units in the U.S. (K&L Gates). The IPO clause is the tail with the most imagination in Cameco's valuation: if the government's Participation Interest has vested before January 2029 and Westinghouse's IPO valuation is then expected to be ≥ US$30B, the U.S. government has the right to require an IPO; the interest converts into a five-year warrant, exercisable for equity corresponding to 20% of the IPO public value, less US$17.5B (same K&L Gates source). Honest characterization: this remains a narrative-stage option (US$80B is an "at least" intended scale, not orders; an IPO depends on the valuation threshold and government willingness), but it is more real than a typical option. It has government backing, a binding document, a clear ≥$30B trigger, and a value allocation formula. It can provide a valuation-reset catalyst for Cameco in the 2028–2030 window, but it cannot be counted as an already realized five-year handoff.

  5. Are there other handoff engines outside Westinghouse? Yes, but none is a five-year second curve.

  • Fuel services (steady cash cow, not a second curve): 2025 output was 14.0M kgU (including 11.2M kgU UF₆, with record Port Hope conversion), and newly signed long-term conversion contracts totaled about 83M kgU UF₆, with conversion prices near historical highs (Cameco SEC 6-K). This is a high-quality business benefiting from scarcity in Western conversion/enrichment, but it is only about 16% of revenue and grows modestly. It is a profit ballast, not a fivefold growth engine.
  • SMR / microreactors (third-curve option, beyond ten years): Westinghouse's AP300 (330MWe, scaled from AP1000, target design certification in 2027, construction start in 2030, operation in the early 2030s), eVinci microreactor, and the SaskPower×Westinghouse×Cameco reactor + fuel supply MOU (Cameco/SaskPower MOU, WNN AP300) commercialize in the 2030s and would let Cameco sell both reactors and fuel, closing the value loop. This is a real third curve, but it is unlikely to contribute profit within five years. Today it is only an emerging option.

  Closing net judgment (pressure on years 3–10): compared with most pure uranium producers, Cameco does have a second curve that has begun to generate cash (Westinghouse), plus a third curve beyond ten years (SMR + fuel loop). On the question of whether it has germinated today, Cameco is more real than peers, and this is one of the few highlights in its Baillie Gifford framework. But put it back on the map: Westinghouse growth is pulse-like, contains accounting distortions, has order depth only in Czech Dukovany, and its largest US$80B/IPO narrative remains an option with triggers. Meanwhile 83% of group revenue still comes from strongly cyclical uranium mining. However bright the second curve is, it does not change the fact that overall earnings are dominated by uranium prices, which is the root of the report's "Watch" rating. Therefore the second curve adds quality points, not a valuation safety margin. It gives a real answer to "what takes over after five years" (Westinghouse reactor construction + nuclear fuel fabrication growth + possible IPO rerating), but it cannot offset the current cyclical peak risk of PE around 107× and a price far above third-party fair values of $47–87. In one sentence: the second curve is the most defensible part of the Cameco story, but what it delivers today is a cash pulse plus an option, not Baillie Gifford's ideal smooth compounding. It deserves an above-middle score, but it is not enough by itself to support a fivefold return over ten years.

  Jun 4, 2026
• QWhat is its core competitive advantage? Will this moat widen or narrow over the next three to five years?6/10

  A

  Conclusion first: Cameco has a rare real structural moat for a cyclical commodity business, built from irreplaceable tier-one high-grade assets, a Western supply security premium, a long-term contract portfolio, full fuel-cycle integration, and capacity flexibility. This is probably its strongest dimension and is clearly stronger than most cyclical stocks. Over the next three to five years, under the nuclear revival and Western supply security themes, the moat's breadth (share security, geopolitical positioning, contract visibility) is likely to widen. But its essence is a resource moat. "Pricing power" is ultimately dominated by the uranium price cycle, not software-like sustainable pricing. In a downturn, even the best assets cannot save profits (2016–2020 is the hard evidence). Net view: real, but a cyclical resource moat; stronger than most cyclicals, yet tightly constrained by the uranium price cycle.

  1. Moat sources: five pillars, most of them difficult to replicate

  ① Tier-one low-cost high-grade assets: the hardest and most irreplaceable pillar. Uranium grades in Canada's Athabasca Basin are 10–100 times the global average. Cigar Lake is the world's highest-grade operating uranium mine and accounts for about 14% of global supply. McArthur River/Key Lake is the world's largest high-grade uranium mine plus mill. High grade translates directly into low cost: the life-of-mine unit costs of the two mines are about US$20.31/lb at McArthur River and US$21.12/lb at Cigar Lake, while current spot is about US$86/lb (as-of 2026-06-04) and the long-term contract price is about US$94/lb (18-year high). This means that even if uranium prices halve to US$40+, these two mines still have thick gross margins. Resource endowment is geological; it cannot be bought or duplicated through capex. This is the part of Cameco's moat closest to permanent, and it will not be erased by competitors' capital spending even under years 3–10 pressure. I agree with the report's judgment that this is one of CCJ's strongest dimensions, and the verified cost numbers make it more concrete.

  ② Western supply security premium: geopolitics turns a quality moat into a political moat. Nearly half of global primary uranium supply comes from Kazakhstan + Uzbekistan, and the nuclear supply chain is deeply tied to Russia. The U.S. Prohibiting Russian Uranium Imports Act (HR 1042, effective 2024-05) requires all waivers to end by 2028-01-01, reduces quotas each year, and unlocks about US$2.7 billion to support the domestic fuel chain. Add Orano's 2024 setback in Niger. The result is that Western nuclear operators are willing to pay a premium for "reliable Canadian supply," and Cameco is the largest Western supplier and the only one with tier-one hard-rock mines. This dimension has strengthened over the past three years and is widening: supply security concerns are moving upstream from enrichment to uranium mining (operators are shifting supply security concerns from enrichment upstream to uranium mining).

  ③ Long-term contract portfolio: turning cyclical visibility into a moat. As of FY2025, after deliveries for the year, Cameco still had about 230M lbs of long-term commitments, averaging about 28M lbs per year over the next five years, with a portfolio extending beyond ten years; the conversion segment has another roughly 83M kgU contracted. This provides multi-year earnings visibility that developers such as NXE/DNN/UEC/UUUU, many of them pre-revenue, simply do not have. The key evidence of pricing power is the 9-year contract with India signed in 2026-03 for about 22M lbs, worth about US$2.6 billion and market-related, with the floor/ceiling midpoint translating to CAD 115–120/lb, far above current realized price. It shows that under the current theme, Cameco can obtain high-quality terms with floor protection and a higher ceiling.

  ④ Vertical integration: the West's rare "full fuel-cycle" platform. Mine → UF₆ conversion → CANDU fuel → 49% Westinghouse (AP1000 reactors + fuel fabrication) is one of the few integrated platforms in the West covering the whole chain. Westinghouse FY2025 adjusted EBITDA reached $780M (+61%). This is genuine differentiation that Kazatomprom and developers do not have. But be honest: Westinghouse still reports accounting losses due to acquisition amortization and has integration and leverage risks. Its moat value is more an option than realized steady-state earnings.

  ⑤ Capacity flexibility: a scarce operating-discipline moat. Cameco can restart or shut capacity in response to price signals (it voluntarily suspended McArthur River in 2018–2022 to support prices) and holds idle tier-one capacity that can be restarted. In an industry known for boom-bust cycles, this discipline of not chasing volume is itself a soft moat that can smooth cycles and protect realized prices.

  2. Next three to five years: breadth likely widens, depth remains constrained by the cycle

  The case for widening (pressure on years 3–10): ① structural demand expansion: WNA expects reactor uranium requirements to rise from about 68,920 tU in 2025 to >150,000 tU by 2040, while primary mine supply covers only about 90% of annual demand and the gap is filled by increasingly depleted inventories; ② the supply security theme strengthens: 2028 expiry of Russian uranium waivers is a hard date that pushes the scarcity of reliable Canadian supply to the foreground; ③ the long-term contract price has risen to an 18-year high and new contract floors are moving up, extending and thickening earnings visibility. All three point to widening moat breadth/duration.

  The case for narrowing (must be offset; no one-sided bull case): ① supply backlash is the most real threat, and a commonly confused distinction needs to be clarified: in 2025-08, Kazatomprom cut its 2026 nominal planned production from 85.21 Mlbs to 77.21 Mlbs (about −10%), while its 2026 YoY guidance still shows +9% to 71.5–75.4 Mlbs, mainly from the ramp-up of Budenovskoye, a JV with Russia. These are not contradictory: the long-term plan is being cut, but 2026 rises YoY because the 2025 base was low, and actual guidance does not even reach the reduced nominal plan. Net reading: supply is recovering but remains constrained by sulfuric acid and production discipline, not out of control. This mildly weakens Cameco's moat but does not collapse it; ② physical funds such as SPUT hold about 72.4 million pounds, and releases at high prices could loosen spot pricing power; ③ a uranium price downturn directly weakens pricing power (see below); ④ technology pathways: SMR/new reactor rollout is slower than the narrative (NuScale Idaho was cancelled in 2023; nuclear projects often overrun budgets and timelines), creating demand-side uncertainty and discounting the pace at which the moat benefit materializes.

  3. The honest boundary: the ceiling of a resource moat is the uranium price cycle

  This must be stated firmly: this moat protects share, cost position, geopolitical position, and delivery visibility, not sustainable pricing power through the cycle. Commodity pricing power ultimately comes from the uranium price cycle. In an upswing there is a Davis double play; in a downturn, even the best tier-one assets cannot save profits. When uranium prices fell into the US$18/lb range in 2016–2020, Cameco owned the same Cigar Lake and McArthur River, yet still had recurring losses or barely profitable years and was forced to suspend production to support prices. This is fundamentally different from software/platform moats, where pricing can be raised sustainably and more users make the network more valuable. Spot has already retreated from US$101/lb in 2026-01 to about US$86/lb, a reminder that the earnings realization of this moat is near a cyclical high and has large downside elasticity.

  Net judgment

  Cameco has a rare real structural moat for a cyclical commodity company. Its core, tier-one high-grade low-cost assets plus a Western supply security premium, is irreplaceable and likely to widen over the next three to five years as 2028 Russian uranium waivers expire and the nuclear revival continues. It is clearly stronger than most cyclical stocks, most developers, and even the lowest-cost Kazatomprom, which wins on cost but loses on geopolitical reliability and integration. But it is a resource moat: breadth (share/geopolitics/duration) is expanding, while depth (pricing power) is always capped by the uranium cycle. This is not an LTGG-style software moat that widens continuously, raises prices sustainably, and expands linearly over ten years. It is a resource moat supported by structural tailwinds but hard-constrained by cycles. In investment terms, the moat's reality supports the claim that this is a top-quality business, but it cannot eliminate the risk from cyclical highs and valuation peaks. That is one of the underlying reasons the report rates it Watch rather than Buy.

  Jun 4, 2026
• QIf its core business is disrupted, does it have the DNA to reinvent itself? How does it handle mistakes and bad news?5/10

  A

  Net view: Cameco has genuine and credible honesty and resilience in how it handles mistakes and bad news. Surviving the decade-long post-Fukushima winter, openly disclosing accidents, and proactively cutting supply to support prices are hard evidence. But its "reinvention" is largely a cyclical commodity company's passive adaptation to the uranium price cycle, not the Baillie Gifford ideal of actively opening an anti-disruption curve when the core paradigm is disrupted. Resilient and honest, but relatively weak in reinvention, so this sits near neutral. Baillie Gifford LTGG asks whether, if the core business is disrupted, the company has the DNA to reinvent itself and how it treats bad news. Cameco scores high on honesty culture and average on proactive anti-disruption reinvention.

  1. Reinvention DNA: real cyclical resilience, but mostly passive adaptation rather than proactive disruption

  The positive evidence is solid and should not be dismissed. Cameco's most persuasive evidence of reinvention is surviving the decade-long winter after Fukushima. After the 2011 Fukushima accident, uranium prices stayed depressed for years, and company revenue shrank from about CAD$2.4B in 2011 to about CAD$1.2B in 2021 (report Section 2.3). Facing both volume and price pressure, it did not dump product to preserve revenue and trample prices. It did the opposite: announced in November 2017 and began in January 2018 the suspension of the flagship McArthur River mine and Key Lake mill, then on July 25, 2018 extended the shutdown indefinitely, resulting in about 550 permanent layoffs. It also cut the annual dividend from CAD$0.40 to CAD$0.08 (down 80%), fulfilling deliveries through long-term contract volumes plus low-priced spot-market purchases, using "disciplined supply" to support prices rather than chase volume (Cameco official announcement, World Nuclear News). In an industry known for violent boom-bust cycles (2007 spot around $137, 2016 below $18), where many peers simply follow the cycle, voluntarily shrinking tier-one capacity to support prices and waiting four full years (2018–2022) until McArthur River restarted in November 2022 is real operating discipline and cycle endurance. Management's tone that "disciplined supply is a strategic cornerstone" and it will not chase volume for volume's sake (report Section 3.4) is backed by action, not empty language.

  But we must distinguish honestly between "resilience" and Baillie Gifford-style "reinvention." A more accurate description of the above is a commodity producer's disciplined contraction and waiting through a uranium downcycle. It reshaped the balance sheet and supply rhythm, but did not open a new paradigm that would keep the business alive if the uranium business itself were disrupted. It survived the winter by waiting for the cycle to return, betting that uranium prices would eventually recover, which they did. This is excellent cycle management, but its essence is passive adaptation to the price cycle, not actively jumping outside that cycle.

  The only move that qualifies as proactive cross-paradigm action is platform transformation: on November 7, 2023, Cameco and Brookfield completed the $8.2B acquisition of Westinghouse Electric, with Cameco holding 49% and Brookfield 51%, extending the business from pure uranium mining (front end) to AP1000 reactors + fuel fabrication (back end), creating one of the West's few integrated full fuel-cycle platforms (Cameco official, NucNet). This is indeed a proactive move to widen the moat and add a second source less exposed to a single commodity's volatility, and it deserves credit. But two discounts apply: ① it is a vertical integration extension, still deeply tied to the main nuclear fuel chain, not a move outside nuclear to hedge the risk of nuclear itself being disrupted; ② as of FY2025, Westinghouse equity-method book net income was only +CAD$58M (depressed by CAD$357M of acquired intangible amortization), and it still carries the history of 2017 bankruptcy and Vogtle project cost overruns from $14B to $36.8B (report Sections 6.2 and 8.4). Integration and earnings realization are still in progress. Today it looks more like an opaque asset with option value than a proven second curve that can withstand disruption.

  2. Handling mistakes and bad news: relatively candid, the strongest part of this question

  This is the dimension where Cameco stands up best under the Baillie Gifford framework. Look at three historical treatments of bad news:

  • It did not hide a major execution failure: Cigar Lake flooding. Shaft 2 flooded in April 2006, and a major water inflow after a rockfall flooded the mine in October 2006. The company disclosed at the time that construction would be delayed by "at least one year" and costs would rise significantly (Globe and Mail). The mine ultimately moved from a planned 2008 startup to 2014, with capex soaring from about $450 million to about $2.6 billion (report Section 2.3). This was a major execution failure of its own, but the company did not conceal it and kept disclosing by milestone.
  • It made difficult decisions in bad years. The 2018 shutdown, permanent layoffs, and dividend cut were an honest response to a market that had broken and could not support production. Management chose to acknowledge weakness, shrink, and sacrifice near-term dividends, rather than pretend everything was fine and keep producing at full capacity into collapsing uranium prices. Being honest with long-term shareholders while making short-term accounts look ugly is exactly the cultural signal Baillie Gifford likes: sacrificing the short term for the long term and facing bad news plainly.
  • Current incidents are disclosed promptly and transparently. On May 10, 2026, after flooding in northern Saskatchewan (partial collapse of the Smoothstone River bridge and disruption of the main supply road), Cameco immediately announced a Key Lake shutdown and McArthur River production reduction. On May 27 it announced both sites had returned to full production, clearly stated that 2026 consolidated production guidance remained unchanged, and also acknowledged that every spring freshet season brings the risk of renewed road restrictions and future delivery delays (Cameco official, NucNet). Bad news was disclosed the same day, the impact was quantified (about 1.5 million pounds under the report's framing), and residual risks were stated without either sugarcoating or panic. This is high-quality crisis communication.

  Net assessment: in how it handles mistakes and bad news, Cameco shows unusual candor for a cyclical resource company: timely disclosure, quantified impact, willingness to admit mistakes and take losses. This is a clear positive.

  3. Anti-disruption ability: tier-one assets + contracts + Westinghouse can withstand pressure, but the moat is more scarce assets + supply security than self-evolution

  Stress-testing the disruption scenarios Baillie Gifford would really worry about, with pressure on years 3–10:

  • If SMR/new reactor types scale: this is more likely a demand positive than disruption. Most SMRs still burn enriched uranium fuel, and more reactors mean more uranium demand. Westinghouse's eVinci microreactor and AP300 SMR also give Cameco a place in the new-reactor cycle. The true tail threat is long-term commercialization of thorium/molten-salt or other non-uranium fuel cycles, but that is more than ten years away and has no scaled precedent to date. It is not a short- or medium-term disruption.
  • If Kazatomprom ramps low-cost supply: this is the most realistic source of "price disruption." Kazakhstan ISR cash costs are significantly below Cameco's hard-rock mines, and a large production increase could crush uranium prices (report Sections 5.1 and 8.4; 2026 production guidance still has conflicting definitions). Cameco's buffer is about 230M lbs of contracted volume plus the capacity flexibility to suspend production again in response to price signals. In other words, its weapon against price disruption is exactly the disciplined contraction proven in 2018. This is the core of its cyclical resilience, but it is still essentially about enduring and waiting.
  • If long-term uranium weakness repeats the Fukushima script: history has already provided the answer. It can survive through a net-cash balance sheet (about $71M net cash under the report's framing), contract floors, and supply discipline. The evidence is credible. But the cost is prolonged weakness in profits and share price (recurring losses/bare profits in 2016–2020), and shareholders must endure a long Davis double kill.

  Anti-disruption conclusion: for "price-type disruption" (Kazatomprom production increases, weak uranium prices), Cameco has discipline that has been proven effective and can withstand it. For "paradigm-type disruption" (non-uranium fuel pathways), its moat, tier-one high-grade assets + Western supply security premium + long-term contracts + Westinghouse integration, is essentially scarce geology plus geopolitical security identity. It is hard to copy but relatively static, not a dynamic capability that self-evolves and repeatedly reinvents itself to resist disruption.

  4. Overall judgment on this Baillie Gifford question

  Putting the two halves together:

  • "How does it handle mistakes and bad news" — strong. Cigar Lake was not hidden, 2018 showed willingness to take losses, and the 2026 flood was transparently disclosed and quantified on the day. The honesty culture holds up and is the highlight of this question.
  • "Can it reinvent itself if the core business is disrupted" — neutral to weak. Surviving the Fukushima decade and buying Westinghouse are real evidence that it has endurance and is willing to expand its boundaries. But its "reinvention" is mainly a cyclical commodity company's disciplined passive adaptation to the uranium price cycle (suspending production to support prices and waiting for the cycle to return), plus one vertical integration move still tied to the nuclear fuel chain. It is not the Baillie Gifford type of self-evolution that actively opens a new anti-disruption curve when the core paradigm is disrupted.

  Therefore, Q5 lands near neutral: Cameco has real cyclical resilience and unusual honesty (clear positives), but its reinvention is more adaptation to cycles than proactive crossing of disruption boundaries, and it lacks second-paradigm-level anti-disruption evolution (clear deduction). For a strong-cycle commodity leader rated Watch, this is appropriate. It can endure and admit mistakes, but do not expect it to create the next decade by repeatedly disrupting itself like a classic Baillie Gifford growth company.

  Jun 4, 2026
• QDoes management, especially the founder, have a long-term view and deep alignment with the company? Is it willing to sacrifice current profits for five to ten years out?4/10

  A

  Net view: neutral to positive. Long-term vision plus countercyclical supply discipline is a real and verifiable positive for Cameco, and it does this better than most cyclical commodity companies. But the trait Baillie Gifford LTGG values most, founder-level long-term vision plus economic interest deeply tied to the company, is structurally absent. Cameco is a professional-manager company born from the merger and privatization of state-owned entities; insider ownership is almost zero (about 0% / less than 1%), and it lacks the founder-heavy alignment seen in a CATL-style Robin Zeng situation. Therefore this question should land near neutral, weaker than companies with founder-heavy ownership and proven profitability.

  1. Long-term vision and countercyclical discipline: real positives, with hard evidence rather than slogans

  The core of this Baillie Gifford question is whether management is willing to sacrifice short-term numbers for long-term value. On this point, Cameco is a rare positive example among cyclical commodity companies, with specific actions rather than empty statements:

  • "Disciplined supply, not volume for volume's sake" is an operating philosophy embedded in the strategic foundation, not situational messaging. The main report records management's tone as "disciplined supply is a strategic cornerstone" and "not volume for volume's sake" (Cameco FY2025 results). The 2025 annual report framing is more explicit: the company "deliberately and conservatively" matches production with the long-term contract portfolio and is unwilling to bring uncommitted tier-one underground inventory to market prematurely, to avoid repeating the oversupply that historically crushed contract cycles. About 230 million pounds of uranium are now locked into long-term contracts extending beyond ten years, with contracts layered in patiently and with discipline (Cameco 2025 Q4/annual report 6-K). This is exactly what Baillie Gifford appreciates: sacrificing current volume and revenue for prices and returns in years 3–10.

  • The hardest evidence is the 2018 voluntary shutdown. During the long uranium downturn after Fukushima, Cameco voluntarily shut the world's largest high-grade mine, McArthur River/Key Lake, in 2018-01 (with about 550 permanent layoffs), fulfilling deliveries through long-term contracts plus market purchases to support prices and avoid selling its tier-one assets cheaply (report Section 2.3). In an industry where operating capacity generates cash flow, shutting the best mine and buying uranium in the market to deliver is textbook countercyclical discipline. This was the most credible real-world test of willingness to sacrifice the short term for the long term, and it was later proven correct when production restarted only after prices recovered in 2022.

  • Capital allocation confirms the same long-term mindset. During the recovery, management restored the balance sheet to net cash (about $71M) and increased dividends (opening section and Section 6 of the report), rather than levering up at a cyclical high to gamble on expansion. This is consistent with a long-term mentality of maintaining discipline at the top and not overextending the balance sheet.

  In years 3–10, this combination of supply discipline, contracted volumes, and capacity flexibility to restart/shut according to price signals is the governance base that lets Cameco get through the next uranium cycle and monetize the scarcity value of tier-one assets gradually over a long cycle. On the "long-term vision" half of the question, Cameco gives a clear yes.

  2. Founder + deep economic alignment: Cameco structurally lacks it, which is a fundamental mismatch with the Baillie Gifford template

  But the other half of Baillie Gifford Q6, and its true preference, is founder-style long-term vision combined with management's economic interest deeply tied to the company (a typical example is Robin Zeng at CATL: founder control plus personal wealth moving with the company, creating an inherent motivation to build the business ten years out). Cameco structurally lacks this trait:

  • No founder; professional-manager governance. Cameco (Canadian Mining and Energy Corporation) was formed in 1988 through the merger and privatization of the federal state-owned Eldorado Nuclear and Saskatchewan's SMDC, two state-owned uranium entities; it listed in Toronto in 1991, on the NYSE in 1996, and Saskatchewan sold its final stake in 2002, completing full privatization (report Section 2.1). From birth, it was not a founder company built from a garage by an entrepreneur, but a professional-manager platform created through state-asset consolidation. There is simply no "founder" subject, so founder-level concentrated ownership and long-term vision cannot exist.

  • Insider ownership is nearly zero, the opposite of concentrated alignment. Insider ownership by management and directors is about 0% (another measure says less than 1%), while institutional investors hold about 68%–73% (GuruFocus CCJ insider ownership, Yahoo Finance: 73% institutional ownership). This means the personal wealth of the CEO/COO is far less intertwined with Cameco's share price than in founder-heavy companies. Their incentives mainly come from compensation and option grants, a standard agent incentive, not owner incentives with personal net worth concentrated in the stock. The Baillie Gifford-preferred binding where the boss is the largest shareholder and loses first if things go wrong is absent at Cameco.

  • The foreign ownership cap is an additional governance constraint, neutral to negative from Baillie Gifford's perspective. Canadian rules write foreign ownership caps into the articles (15% for a single non-resident, 25% in aggregate, report Sections 2.1 / 3.4). This supports its identity as a reliable Canadian supplier, which is positive for the moat, but it also means no single long-term shareholder can build a concentrated position and become deeply aligned. This creates institutional friction with Baillie Gifford's habit of holding large long-term stakes and accompanying great companies for ten years, while externally closing off the possibility of a founder-like major shareholder emerging.

  Net effect: on the "deep alignment of interests" half of the question, Cameco gives a no. This is not because management is incompetent, but because the ownership structure is fundamentally mismatched with the Baillie Gifford template.

  3. Succession: a gradual "president first" handoff that still needs tracking (neutral, incomplete)

  Another implicit Baillie Gifford requirement for founders/core leaders is continuity in long-term stewardship. Cameco is neutral here and in transition:

  • The current CEO is still long-tenured leader Tim Gitzel. He has served as president and CEO since July 2011, about 14–15 years to date, and remained in office as of 2026-06 (Cameco leadership). His long tenure is indirect evidence of long-term vision: he has lived through the full cycle of the Fukushima winter, voluntary shutdowns, recovery, and Westinghouse acquisition, and is the executor of the supply discipline described above.

  • A gradual "president first" succession is underway. In July 2025, the company announced management changes: Grant Isaac would be promoted from CFO to President & COO from 2025-09-01, widely viewed as the succession candidate; Heidi Shockey would become CFO, while former COO Brian Reilly and chief legal officer Sean Quinn would move into advisory roles and retire in 2026-03 (Cameco leadership, ainvest report). But as of 2026-06, Isaac had not yet become CEO and Gitzel remained CEO. This is a gradual handoff with president first and the CEO staying for now, intended to smooth the transition and preserve Gitzel's institutional memory.

  In years 3–10, this is a controlled but unfinished succession. Positively, Isaac is an internal veteran who has long participated in strategy, so the disciplined supply philosophy is likely to continue and abrupt transition risk is low. But the final timing of the CEO handoff and whether the new CEO will maintain the same countercyclical discipline remain open variables. They belong on the long-term tracking list, which is why item 7 of the report's tracking dashboard focuses on CEO/COO statements on capital allocation and supply discipline.

  4. Net judgment (conclusion)

  Combining the three points: long-term vision and countercyclical supply discipline are real positives, backed by hard evidence from the 2018 voluntary shutdown, the net-cash balance sheet, and dividends, and better than most cyclical commodity companies. Founder + deep economic alignment is structurally absent: this is a professional-manager company created from state-owned privatization, with near-zero insider ownership and foreign ownership caps that prevent concentrated shareholder alignment, a fundamental mismatch with the Baillie Gifford template. Succession is a gradual "president first" handoff, controlled but incomplete and requiring tracking.

  Therefore the honest landing point is neutral to positive, not a high score. Cameco's management is trustworthy and long-term discipline is verifiable, but what it gives investors is excellent professional managers plus institutionalized supply discipline, not the Baillie Gifford ideal of a founder with personal net worth tied to the company for the next ten years. Compared with companies where founders own heavily and profits are already stable, such as CATL under Robin Zeng, Cameco is clearly weaker on this dimension. The quality of long-term vision is good, but the form of economic alignment does not fit. This is consistent with the overall tone of the report: a high-quality leader, but with asymmetric risk/reward and a Watch rating. Management is not the weak point of this investment, but it also cannot provide the extra certainty of founder-level long-term alignment in the Baillie Gifford framework.

  Jun 4, 2026
• QIf it disappeared tomorrow, how much would customers miss it? Is its growth model sustainable and not dependent on harming society or regulation?6/10

  A

  Net view: in the context of Western supply security, Cameco's indispensability is quite high, growth sustainability is its strongest dimension, and the social/regulatory dimension is favorable and clean. These three layers, especially the latter two, are the parts of this strong-cycle commodity company that best withstand Baillie Gifford's ten-year scrutiny. But be honest: it is not an absolute global monopoly (Kazatomprom in Kazakhstan can still supply uranium), and the one hard constraint in the whole logic remains the uranium price cycle. In one sentence: if it disappeared tomorrow, Western nuclear operators would miss it greatly; and its self-funded, clean, Western-supply-security-positioned growth model is not intrinsically harmful to society or regulation.

  ---

  ① Indispensability: if Cameco disappeared tomorrow, Western nuclear operators would miss it badly, but it is not globally irreplaceable.

  Under years 3–10 pressure, nuclear fuel is a chain where switching suppliers is measured in years, not weeks. Uranium exploration to production often takes a decade (the report's Cigar Lake example, launched in 2004, delayed by two floods until 2014 startup, with costs rising from $450 million to $2.6 billion, shows how hard it is to add Western tier-one capacity). Long-term contracts run 5–10 years, and conversion/enrichment capacity is even more oligopolistic. This means Cameco's position is not this quarter's market share, but a hard-to-replicate portion of reliable uranium supply that the West can dispatch over the next decade. To gauge how much it would be missed, look at three points:

  • It sits in a geopolitically fragile supply structure deeply tied to Russia. Global primary uranium supply is highly concentrated: Kazatomprom, including JVs, accounts for more than 40% of global supply and is twice Cameco's scale, and Kazakhstan uranium has long been exported through Russia. This chain has been cut by policy since 2024: the U.S. Prohibiting Russian Uranium Imports Act was signed in 2024-05 and took effect in 2024-08, targeting Russian supply that still accounted for about 27% of U.S. civilian reactor enriched uranium demand in 2023, while also unlocking $2.72 billion (including $700 million for HALEU) to support the domestic nuclear fuel chain.
  • The scarcity of "reliable Canadian supply" is being repeatedly validated by real events. The most persuasive evidence is not narrative but incidents: even Cameco's own Kazakh JV mine, JV Inkai, had shipments of its Kazakhstan uranium temporarily suspended in early 2025 because exports had to pass through Russia; France's Orano saw its Niger assets taken over by the military government in 2024. As the cheap barrels in Kazakhstan and Niger are increasingly marked with geopolitical risk, the scarcity premium of "produced in Canada's Athabasca, not routed through Russia, and integrated across the fuel cycle" should widen over time rather than converge. This is a structure that can keep realizing value in years 3–10.
  • What is hard to replace quickly is the combined package of locked volume + tier-one assets + integrated platform. The report states that Cameco has about 230 million pounds of contracted volume and average deliveries of about 28M lbs per year over the next five years, owns operating uranium mines with grades 10–100 times the global average (Cigar Lake, McArthur River), and extends the chain through 49% Westinghouse into reactors and fuel fabrication. This is one of the West's rare full-cycle platforms from mine → conversion → fuel → reactor. If operators really had to remove Cameco from their fuel plans, no single competitor could replace the same Western, reliable, integrated, contracted combination within a few years.

  Honest landing point: indispensability is context-relative. In the context of Western supply security, it is quite high (there is almost no equivalent short-term substitute). Globally, Kazatomprom and others can still supply uranium, and uranium molecules are not exclusive to Cameco. So it is a pillar in the Western camp, not a global monopoly. Baillie Gifford's question of how much customers would miss it: Western operators would miss it greatly; other markets less so.

  ② Growth sustainability: this is Cameco's strength and the cleanest dividing line between it and cash-burning uranium developers.

  When Baillie Gifford asks whether growth is sustainable, the core question is what funds the growth. Cameco's answer is self-funding, not financing dependence:

  • It relies on operating cash flow + contract coverage + net cash, not share issuance and cash burn. FY2025 revenue was $3,482M (+11%), adjusted EBITDA $1,929M (+26%), net income attributable to shareholders $590M, operating cash flow about CAD 1.4 billion, the balance sheet returned to net cash (about $71M), and the company raised the annual dividend to $0.24 and accelerated the plan by one year. A company that can be net cash and raise dividends during an expansion cycle is not relying on capital-market charity for growth.
  • The contrast with peers is stark. In the report's peer comparison, NXE, DNN, and UEC are mostly pre-revenue or loss-making developers. Their "growth" depends heavily on continued financing and uranium price realization, making them essentially options. Cameco's growth is built on contracted delivery volume: 230 million pounds of long-term contracts plus average annual deliveries of about 28M lbs over the next five years, giving multi-year cash-flow visibility. This lock-volume-first, self-fund-second growth has a much stronger sustainability base than cash-burning peers.
  • The only constraint, but a hard one, is the uranium price cycle. Following the report's framing, long-term contracts are buffers with lag and floor/ceiling, not insulation. They smooth the cycle but do not eliminate it. Spot has retreated from about $101/lb in 2026-01 to about $86/lb in early 2026-06, while the long-term contract price has risen to about US$94/lb, an 18-year high. The growth model is sustainable in that its funding mechanism is healthy, but the growth rate remains tied to the uranium price path. The report's Watch rating comes from this: the way of living is sustainable; the speed of growth is uncertain. These are not contradictory.

  ③ Society and regulation: low-carbon baseload + policy tailwinds + clean compliance. Cameco almost does not trip on this dimension.

  The second half of Baillie Gifford's seventh question, whether growth does not harm society and regulation, is broadly positive for Cameco:

  • It sells low-carbon baseload energy and stands with policy tailwinds, not headwinds. COP28 launched the pledge to triple nuclear energy by 2050, and signatories have grown from the initial 20-plus countries to 30-plus (including the U.S., Canada, France, Japan, and the U.K.); the U.S. 2024 Russian uranium ban is not just an import ban, but $2.72 billion of real support for the domestic nuclear fuel chain. In other words, regulation is not a threat to Cameco's growth. It is actively supplying capital and clearing space for Western uranium. Add the nuclear revival ignited by AI data center power demand (Microsoft's Three Mile Island restart, Google/Amazon nuclear power agreements), and this theme is favorable in years 3–10.
  • It monetizes through compliant, clean channels, not gray zones. Uranium is a heavily regulated industry, but Cameco's selling point is precisely an auditable, traceable Western supply chain: foreign ownership caps in Canada are written into the articles, contracts are transparent, and the supply chain is visible. Its growth does not depend on harming society or evading regulation. Conversely, long-tail social debates such as nuclear waste and nuclear safety belong to the entire nuclear industry, not a Cameco-specific deduction.

  ---

  Net Baillie Gifford landing point: measured by the LTGG yardstick, Cameco gives one of the cleanest Q7 answers in the sector: indispensable (a Western supply security pillar that operators would miss tomorrow), sustainable (self-funded, net cash, contracted volumes, not cash-burning), and clean with tailwinds (low-carbon baseload, policy support, compliance and transparency). These three layers, especially the last two, are genuinely robust under ten-year scrutiny for a strong-cycle commodity stock. But Baillie Gifford would also ask whether this is enough to support a fivefold return over ten years. That answer goes back to the uranium price cycle and the current valuation, which already includes a significant premium (Watch rating, with margin of safety waiting for a price around $80). On Q7 itself: strong, and honestly strong. It does not change the overall judgment of good business, expensive price, but it explains why the business is expensive with some substance.

  Jun 4, 2026
• QWhat are the unit economics of this business (gross margin, incremental returns)? Do they improve or deteriorate as scale grows? Where does the money it earns go?5/10

  A

  Net view (conclusion first): unit economics at the cyclical high look genuinely attractive: uranium segment adjusted EBITDA margin of about 44%, net cash, and strong cash generation. But these margins are tightly tied to uranium prices. They are cyclical dividends, not stable unit economics through the cycle. As scale grows through restarting idle tier-one capacity, incremental returns depend on restart costs versus uranium prices, and the unit cost structure is inferior to Kazatomprom's ISR. This commodity business's unit economics fluctuate with price cycles rather than improving monotonically. By Baillie Gifford's standard of repeatable improvement in unit economics after scaling, CCJ sits near neutral, and a conservative score is appropriate.

  ① Current unit economics: at a cyclical upswing high, they look quite healthy

  Looking by segment, CCJ's current unit economics are strong in absolute terms: in FY2025 (CAD basis), uranium segment revenue was CAD$2,874M, and segment adjusted EBITDA was CAD$1,255M, implying an adjusted EBITDA margin of about 44%. Uranium realized price was US$62.11/lb (=CAD$87.00/lb, +9% YoY), sales volume was 33.0M lb, and production was 21.0M lb. Companywide adjusted EBITDA was CAD$1,929M (+26%), net income attributable to shareholders was CAD$590M, and the balance sheet returned to net cash (~$71M).

  Momentum is still upward: Q1 2026 adjusted EBITDA rose to CAD$509M (+44%), uranium realized price was US$66.21/lb, and the official framing says uranium segment gross profit rose +28%, driven by higher realized prices and lower unit cost of sales. In other words, during the cyclical upswing, higher realized prices plus lower unit costs create typical operating leverage. This is the best-looking part of the first half of a commodity cycle. But remember: it looks good in the first half of the cycle, not necessarily across the cycle.

  ② Strong cyclicality is the core qualifier: margins are highly tied to uranium prices, with Davis double plays and double kills

  This is the real center of Q8. The 44% segment margin is not CCJ's natural state; it is a function of the current US$60+/lb realized price. When the numerator (realized price) moves, the entire margin structure is repriced:

  • Upswing Davis double play: rising price + rising sales volume + lower unit costs through spreading fixed costs amplify margins and cash flow in the same direction (the current situation).
  • Downcycle Davis double kill: uranium is famous for violent boom-bust cycles (spot reached about $137/lb in 2007 and fell below $18/lb in 2016). In a deep downturn, CCJ's unit economics do not merely see margins fall gently; they turn negative. After Fukushima, uranium prices stayed depressed for years, and CCJ recorded a net loss of about −$62M in 2016 (including a $362M impairment) and about −$205M in 2017. The 2016–2020 period was marked by recurring losses or barely profitable years. Today's 44% margin was negative in those years.
  • Contract floors are partial support, not immunity: CCJ's long-term contract portfolio (about 230M lbs contracted, average about 28M lbs per year over the next five years, mixing base-escalated and market-related contracts with floor/ceiling) makes realized prices lag spot and gives floor protection on the downside. That is why CCJ is more disciplined than pure spot producers. But floors cushion the slope; they do not save the business from a deep and persistent downturn. In 2016–2020 this contract mechanism was already operating, and the segment was still dragged into losses. Floors smooth volatility; they do not change the underlying fact that unit economics are governed by uranium prices.

  ③ Do unit economics improve or deteriorate as scale grows? Incremental returns depend on restart cost versus uranium price, and the cost structure is inferior to ISR

  Baillie Gifford asks whether unit economics improve as scale grows. For CCJ, this needs two layers, and both point away from a monotonic improvement story:

  • Returns on incremental capacity are determined by price, not scale: CCJ's main way to increase production is restarting idle tier-one capacity (McArthur River/Key Lake was voluntarily suspended in 2018–2022 to support prices and restarted from 2022), with 2026 production guidance of 19.5–21.5M lb. This capacity flexibility is an advantage, because output can be switched according to price signals. But it also means the return on the incremental pound depends on restart/ramp marginal cost versus the prevailing uranium price. At high prices, restarting production is highly accretive (as now); at low prices, restarting destroys value, which is why the company chose to shut down before. So "larger scale → better unit economics" is not structurally inevitable for CCJ; it is a conditional function of price.
  • Across production methods, the unit cost structure is inherently disadvantaged: CCJ's tier-one hard-rock mines (Cigar Lake, McArthur River) have grades 10–100 times the global average and top-tier resource quality, but the mining method is hard rock, and the unit cost structure is inferior to Kazatomprom's ISR (in-situ recovery). Kazatomprom is the world's lowest-cost ISR producer, with ROE around 32% and EV/EBITDA only about 9.5×. In the same uranium price environment, ISR has better unit economics and valuation absorption capacity. This shows that CCJ's high margins come more from the cycle plus the Western supply security premium than from the industry's best unit cost curve. Scaling up cannot turn hard-rock cost structure into ISR.

  ④ Honest landing point: cyclical dividend does not equal repeatable unit-economic improvement

  Putting the above together against the Baillie Gifford yardstick: LTGG values unit economics that can continue to improve repeatably after scale, like software's declining marginal cost or a platform's network effects. CCJ is not in that class. Its unit economics are a mirror of the commodity price cycle: attractive in the upswing and negative in the downturn. Contract floors smooth but do not remove the volatility. Incremental returns from restarts are determined by price rather than scale, and the underlying cost structure is not the best in the industry. The current 44% segment margin and net cash are to a large extent a cyclical dividend from uranium prices near historical highs in 2024–2026, not a unit-economics curve rising through the cycle.

  The positive side still deserves recognition: compared with other cyclical commodity producers, CCJ's unit-economic quality is above average. Contract discipline, capacity flexibility, net cash, and a Western supply security premium make it more resilient and more controlled in pricing than peers. That is also why the report rates it Watch rather than Avoid. But "more resilient than peers" is not the same as "stable high unit economics through the cycle."

  Overall, Q8 should be near neutral and conservative: unit economics at the cyclical high look attractive and cash generation is strong, but sustainability is dominated by uranium prices, moving with cycles rather than improving monotonically. Incremental returns are a conditional function of price, and the cost structure is inferior to the best ISR model. By Baillie Gifford's standard of repeatable improvement in unit economics after scaling, this business cannot earn a high score, so conservatism is appropriate.

  Jun 4, 2026
• QWhat conditions must hold simultaneously for it to rise fivefold over ten years? Are those conditions realistic? What expectations are embedded in today's share price?2/10

  A

  Net view: weak (low Q9 score). For Cameco to rise fivefold over ten years, from US$114.02 to about $570 and market value from $50.05B to about $250B, four things must happen simultaneously: a uranium supercycle keeps making new highs and holds above prior peaks, production and sales volumes expand materially, Westinghouse growth materializes and perhaps earns an IPO rerating, and a peak valuation is not killed by a cyclical downturn for ten years. Yet this is a strong-cycle commodity stock currently near a cyclical high, with spot already down from its $101 peak, valuation at absolute historical highs (PE about 107×, EV/EBITDA about 50–78×, third-party fair values only $47–87 and below the current price). Entering from a cyclical peak plus a valuation peak, a fivefold ten-year return is not very realistic, and the risk of permanent capital loss is real. This is the opposite of Baillie Gifford's ideal: buying a misunderstood company at a dislocated low before the market notices.

  1. First do the math: what do $570 / $250B require?

  Current price is $114.02, shares outstanding are 435.5M, and market cap is $50.05B (stockanalysis). A fivefold return over ten years means:

  • Share price $114 → about $570 (4.2 times the historical high of $135.24 and 6.6 times the upper end of third-party fair value at $87);
  • Market cap $50.05B → about $250B.

  What does $250B mean? It is more than the combined market value of all companies globally that can be called uranium/nuclear names. Under companiesmarketcap, 39 global uranium concept companies, including nuclear power operators/reactor makers such as China National Nuclear Power, BWX, and Oklo, have a combined market cap of only about $194.86B (companiesmarketcap). In other words, for Cameco alone to reach $250B, it would have to exceed the current market value of the entire global uranium/nuclear sector by itself. Looking only at pure uranium miners, Cameco $50B + Kazatomprom about $19B + NexGen about $7.5B + other developers totals far below $100B (companiesmarketcap, stockanalysis). This is not the starting point of a cheap company the market has not noticed; it is an already richly priced leader trying to deliver another order of magnitude of expansion.

  Decomposed into multiples, a fivefold return requires both earnings multiple and valuation multiple contributions. Four conditions are necessary:

  1. The uranium supercycle keeps making new highs and holds above prior peaks. Spot must not only recover from about $86/lb today to the January $101 high, but stay at higher levels for a long time, approaching or exceeding the historical 2007 peak of $137; long-term contract prices must step up again from today's 18-year high of about $94/lb. This is the root of the earnings numerator.
  2. Production/sales volumes expand materially. Contracted volume is about 230M lbs, average annual deliveries over the next five years about 28M lbs, and 2026 production guidance only 19.5–21.5M lb (Q1 2026). For fivefold earnings, price alone is not enough; Athabasca tier-one capacity must keep expanding volumes and avoid incidents like the 2026-05 Saskatchewan floods that caused production reductions.
  3. Westinghouse growth materializes and perhaps earns an IPO rerating. Cameco holds 49%, book results are still loss-making (depressed by acquisition amortization, with 2026 guidance for a book net loss of US$(75)–(10)M), and value has to come from continued adjusted EBITDA realization (FY2025 US$780M), AP1000 new orders converting into construction notices, and eventual release of hidden value through the clause allowing the U.S. government to require an IPO if valuation is ≥$30B (FY2025 results).
  4. The peak valuation is not killed by a cyclical downturn for ten years, and may even expand further. This is the harshest condition, as discussed below.

  2. Reality check, item by item: every condition faces headwinds

  ① This is a strong-cycle commodity stock, and it is currently near a cyclical high, with spot already rolling over. Uranium is a famously volatile commodity: about $10 in 2003 → about $137 at the 2007 peak → below $18 in 2016 → about $106 in 2024-01 → about $101 in 2026-01 and then down (Trading Economics, INN). The latest spot is about $86/lb (carboncredits), so the entry point is already on the right side after the January peak. One prerequisite for a fivefold ten-year return is new uranium price highs, but the starting point is exactly where the cycle has already turned. That is a completely different payoff from buying at the $18 low in 2016.

  ② Valuation is already at absolute historical highs, making another fivefold expansion from the top extremely difficult. PE-TTM is about 107×, forward PE about 67–92×, EV/EBITDA about 50–78× (10-year median about 33×, 13-year range 7×–95×), and P/B about 9× (3-year average 5.4×, 5-year average 4.2×), all near historical peak ranges (stockanalysis, GuruFocus). Third-party fair values of $47–87 (GF Value $64.62, Simply Wall St DCF about $47, Intellectia $52–87) are generally below the current price of $114. Starting from the top of the valuation band and above fair value, it is almost impossible for valuation expansion to contribute meaningfully to returns. A more reasonable neutral assumption is reversion toward the historical median (about 33× EV/EBITDA), which is itself a headwind. In other words, almost the entire fivefold return must be carried entirely by earnings, but those earnings are cyclical-high earnings and can reverse.

  ③ Cyclical stocks can halve through a Davis double kill, and the script exists. The damage in cyclicals comes from the combination of earnings downgrades and multiple compression. If uranium prices reverse, Cameco's realized price follows with a lag through contracts and the earnings numerator shrinks, while the market compresses a cyclical-high PE toward the center. Both sides move against the stock. History is close: uranium collapsed from $137 in 2007 to 2011, post-Fukushima revenue shrank from about CAD$2.4B in 2011 to about CAD$1.2B in 2021, and 2016–2020 brought recurring losses or barely profitable years (2021 net income attributable to shareholders was −CAD$103M). Seeking Alpha already downgraded the playbook from "Buy-and-Hold" to "Buy the Dips and Sell the Rallies" on 2026-01-30, citing forward P/E around 4 times the S&P and NAV only about one-third of market cap (report Section 8.3). Permanent capital loss is not a tail assumption; it is one base-case possibility for this kind of stock at a cyclical peak.

  ④ All four conditions must hold simultaneously, making joint probability low. The four conditions above are not optional. They all must be true to support $570. Each one has real headwinds on its own: uranium has peaked and pulled back, valuation is at the top, Westinghouse still shows accounting losses, and operations can suffer incidents. The joint probability is further compressed. This is the opposite structure of an ideal Baillie Gifford LTGG stock, where multiple growth legs naturally reinforce one another in the upside case and the analytical pressure sits on long-term value in years 3–10. Here, years 3–10 will likely include at least one cyclical downturn, and that is precisely when cyclical stocks suffer most.

  3. Does today's price already embed optimistic expectations? Clearly yes

  No hedging is needed: the market has already priced the nuclear revival plus higher uranium prices fully, and perhaps excessively. The share price has risen from about $10 in 2020 to $114 (about 11 times), putting the AI data center power → nuclear revival → uranium supply deficit narrative, the Westinghouse platform, and the potential IPO option into a PE of 107× and a $114 price. Third-party DCF/NAV fair values are only half to four-fifths of the current price. So today's Cameco is not a cheap company that the market does not understand, does not respect, or cannot see far enough to appreciate. It is the opposite: the market has understood it and priced it on a very optimistic path. The honest answer to Baillie Gifford's question of why the market has not yet realized the company's greatness is that the market has realized it already and paid a premium for it. The surprise is more likely on the downside (uranium price disappoints, valuation reverts toward fair value) than on the upside.

  4. Honest landing point

  Buying a strong-cycle commodity stock from both a cyclical peak and a valuation peak and requiring a fivefold return over ten years means uranium prices must keep making new highs and hold them, production/sales must expand, Westinghouse must deliver and IPO, and the peak valuation must avoid being killed for ten years. Every condition faces real headwinds, and the starting point is already on the right side of "spot down from $101 and valuation above fair value." The realism of a fivefold ten-year return is low, and the risk of permanent capital loss is real. This is the sharp opposite of Baillie Gifford's ideal: buying at a misunderstood or dislocated low before the market notices, then letting multiple growth legs naturally reinforce the upside case. Here, it is a cyclical top already priced for optimism, not an unseen great company. The report's Watch rating and desire to wait for a margin of safety around $80 are the price expression of that judgment. Q9 should score low.

  Jun 4, 2026
• QWhy has the market not realized all this yet? Does it not understand, not respect, or not see far enough? What becomes the "narrative inflection point"?3/10

  A

  Net view: on Q10, Cameco is the mirror image of Baillie Gifford's ideal stock. The market is far from not realizing the story; it has already priced the nuclear revival theme and uranium price upside fully, perhaps excessively. Baillie Gifford's Q10 question of why the market does not understand this great company almost does not apply here. There is no cognitive-blind-spot mispricing, only a star already under bright lights. This is a low-score item. Across the three layers of not understanding, not respecting, and not seeing far enough, the only potentially underappreciated piece is the Westinghouse IPO option, but that is a multi-year option, not current margin of safety.

  ① Not understood? Basically no. The market understands it very clearly. Baillie Gifford's ideal "not understood" case involves a complex business, an early narrative, sparse coverage, and a market that has not yet grasped the company's greatness. Cameco is the opposite. Nuclear revival (AI data center power demand → Microsoft restarting Three Mile Island, Google/Amazon signing nuclear power agreements) has been one of the most crowded market themes since 2024. Everyone knows it. Sell-side coverage is dense, with a consensus Buy (S&P Global framing: 23 analysts, consensus Buy, average target about $137.86; MarketBeat shows targets around $148), median target around $134–140, and a range of about $82–175. The main report also confirms it is the world's largest publicly listed uranium producer and a pillar of the Western nuclear fuel cycle. Its moat, Athabasca tier-one high-grade assets, Western supply security premium, about 230 million pounds of long-term contracts, and Westinghouse integration, is fully recognized by the market. When PE-TTM stands around 107× (stockanalysis CCJ statistics page, with recent readings around 110×), by definition it cannot be an obscure name the market does not understand. The market has understood it and assigned a top-tier valuation.

  ② Not respected? The direction is exactly the opposite. It is not being dismissed; it is being chased too hard. Baillie Gifford's "not respected" case is where the market gives a truly great company a low valuation because near-term numbers look ugly, it has a cyclical label, or ESG prejudice weighs on it. Cameco is the opposite. The market has not underestimated it; it has prepaid the nuclear revival plus uranium price upside too fully. The stock has risen from about $10 in 2020 to about $114, roughly 11 times (Seeking Alpha frames it as about +1,300% since early 2020). PE-TTM is about 107×, EV/EBITDA about 50–78× (GuruFocus around 50×, above the 10-year median of about 33×), and P/B about 9×, all near historical valuation-band peaks. Third-party fair values are generally below the current price: GuruFocus GF Value about $64–69 and labels it significantly overvalued, Intellectia's relative valuation fair range about $55.63–93.73, implying about 18% overvaluation versus current price, and the report cites Simply Wall St DCF around $47. The strongest counter-evidence comes from a bullish seller's own shift: on 2026-01-30, Seeking Alpha changed the playbook from "buy and hold" to "buy the dips and sell the rallies", citing forward P/E around 4 times the S&P, uranium reserve NAV only about $18.5B, roughly one-third of a market cap around $55B, and explicitly giving a re-entry condition of PE below 100 and a move toward $80 before adding. This is not a market that looks down on the company and misprices it cheaply. It is a market that thinks too highly of the story and has already paid up. The real issue is mean reversion from excessive optimism while waiting for earnings and uranium prices to prove the story, which is the opposite of Baillie Gifford's search for underappreciated greatness.

  ③ Not seeing far enough? The only possible underappreciated layer, but it is option value, not current margin of safety. If the market may be "not seeing far enough" somewhere, it is the long-duration option value of Westinghouse (Cameco's 49% stake). On 2025-10-28, Westinghouse's two shareholders (Cameco/Brookfield) reached a framework with the U.S. Department of Commerce to support at least US$80B of new reactors in the U.S.; it includes an IPO clause: if the government's interest vests by January 2029 and the Westinghouse IPO valuation reaches $30B or more, the government can require an IPO and purchase equity equivalent to 20% of the public company's fair value. Westinghouse FY2025 adjusted EBITDA was about US$780M (report framing +61%), but book results remain loss-making because of acquired intangible amortization. This asset is visible but hard to value. The realization window is years away (the clause anchors on January 2029 and depends on final investment decisions and firm new-build contracts), so the market may underprice it. But that is precisely option value, not current margin of safety. The current price of about $114 already sits far above the upper end of third-party fair value that includes Westinghouse (about $87–93). That means the market has not missed Westinghouse; it has counted an optimistic scenario before Westinghouse lands it. Baillie Gifford would value this kind of long-duration option, with pressure on years 3–10, but only if the entry price leaves margin of safety. Cameco's problem is not that the market cannot see far enough; it is that the current price does not let you buy that far-dated option at a discount.

  ④ What is the narrative inflection point? It is verifiable evidence of delivery, not correction of perception. For an ideal Baillie Gifford stock, the inflection point is often a cognitive rerating when the market finally understands greatness. For Cameco, the inflection point is a set of hard signals that can be directly confirmed or falsified by financial statements and uranium prices: (a) whether uranium prices can break prior highs rather than continue rolling over (spot has fallen from about $101 in 2026-01 to about $86/lb, briefly below $85 at the end of May; long-term contract price is about $94/lb at an 18-year high, and bank uranium forecasts range widely from $80 to $150, with dispersion itself showing upside is no longer consensus); (b) whether a Westinghouse IPO lands and whether valuation triggers the ≥$30B clause; (c) whether current valuation can be digested by earnings growth (FY2025 revenue CAD$3,482M, adjusted EBITDA CAD$1,929M, net income attributable to shareholders CAD$590M, net cash), or instead reverts toward third-party fair value (about $47–87). In other words, Cameco does not need a narrative inflection point to wake up market cognition. It needs fundamental evidence to deliver on optimism that has already been prepaid. That is a different kind of inflection from Baillie Gifford's preferred setup of the market not yet realizing a company just before a cognitive rerating.

  Conclusion (Q10 net view): low. The soul of Baillie Gifford Q10 is asking why the market has not yet realized the company's greatness. Cameco is a star cyclical commodity company where the market has already realized the nuclear revival story and paid a high price for it: sell-side consensus Buy, 22+ analysts covering, PE about 107×, share price up about 11 times in 5 years, valuation at historical peaks and above most third-party fair values, and even bullish commentators changing their playbook to "buy dips, sell rallies." It is not a mispriced gem in a cognitive blind spot. It is the mirror image of Baillie Gifford's ideal entry point: buying before the market notices, with margin of safety. The only potentially underappreciated Westinghouse IPO option is years away, does not provide current margin of safety, and has already been pulled forward into a current price around $114. Honest landing point: this is a leader already fully, perhaps excessively, priced, not a cheap great company the market does not understand or respect. This matches the report's view of Watch and waiting for a price around $80 before discussing margin of safety. Q10 should score low.

  Jun 4, 2026